Cargando…
Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis
BACKGROUND: Disease activity in multiple sclerosis (MS) is defined as presence of relapses, gadolinium enhancing lesions and/or new or enlarging lesions on MRI. It is associated with efficacy of immunomodulating therapies (IMTs) in primary progressive MS (PPMS). However, a thorough review on disease...
Autores principales: | Blok, Katelijn M., van Rosmalen, Joost, Tebayna, Nura, Smolders, Joost, Wokke, Beatrijs, de Beukelaar, Janet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661414/ https://www.ncbi.nlm.nih.gov/pubmed/38020591 http://dx.doi.org/10.3389/fneur.2023.1277477 |
Ejemplares similares
-
Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment
por: Bruijstens, Arlette L, et al.
Publicado: (2020) -
Distinct Effector Programs of Brain-Homing CD8(+) T Cells in Multiple Sclerosis
por: Koetzier, Steven C., et al.
Publicado: (2022) -
Health-economic benefits of anti-CD20 treatments in relapsing multiple sclerosis estimated using a treatment-sequence model
por: Smets, Ide, et al.
Publicado: (2023) -
Should anti-CD20 be used as an immune reconstitution
therapy?
por: Smets, Ide, et al.
Publicado: (2022) -
Vitamin D and Multiple Sclerosis: Correlation, Causality, and Controversy
por: Smolders, Joost
Publicado: (2010)